Are you Dr. Traweek?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
201 Seton Pkwy
# Seton
Round Rock, TX 78665Phone+1 512-814-0298Fax+1 512-597-2713
Summary
- Dr. Stephen Traweek, MD is a board certified pathologist in Round Rock, Texas. He is currently licensed to practice medicine in Texas, Ohio, and Virginia. He is affiliated with Cedar Park Regional Medical Center and University Medical Center at Brackenridge.
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Hematopathology, 1985 - 1986
- Oregon Health & Science University (OHSU Health)Residency, Pathology-Anatomic and Clinical, 1981 - 1986
- North Central Texas Medical FoundationInternship, Transitional Year, 1980 - 1981
- University of Texas Southwestern Medical SchoolClass of 1980
Certifications & Licensure
- CO State Medical License 2002 - 2025
- TX State Medical License 1980 - 2025
- CA State Medical License 2006 - 2023
- FL State Medical License 2011 - 2023
- NM State Medical License 2005 - 2022
- NY State Medical License 2006 - 2022
- AZ State Medical License 2005 - 2021
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsDetection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.S. Thomas Traweek, Jane Liu, Rita M. Braziel, Rochelle M. Johnson, Russell K. Brynes
Diagnostic Molecular Pathology. 1995-09-01 - 12 citationsPreoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.Gregory W Randolph, Julie Ann Sosa, Yangyang Hao, Trevor E Angell, David C Shonka , Jr
Thyroid. 2022-09-01 - 377 citationsMonoclonal Antibodies against EGFRvIII Are Tumor Specific and React with Breast and Lung Carcinomas and Malignant GliomasCarol J. Wikstrand, Laura P. Hale, Surinder K. Batra, M. Leslie Hill, Peter A. Humphrey
Cancer Research. 1995-07-15